Orbimed Advisors LLC, Director, 10% Owner at Electra Therapeutics, Inc. (ETRA), bought 1,333,333 shares at $15.00 ($20.0M) on 2026-09-21, disclosed to the SEC on 2026-09-23.
Orbimed Advisors LLC purchased $5M of ETRA stock at $15.00, marking the largest insider purchase in the company's history. This significant capital commitment suggests high conviction in the company's near-term prospects.
The stock is currently trading at $15.00, which is 100% below its 52-week high of $30.00, indicating the purchase occurred at a substantial discount to recent highs.
Insider purchased $5M, the largest ever trade in company history; track this momentum.
Insufficient data — needs manual review
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 333,333 | $5.0M | 25.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 75.0% |
| Total | $15.00 avg | 1,333,333 | $20.0M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |
| SION | SELL | 2026-07-02 | $5.3M | — | Filing → |